Impact Of Rising Diabetes Prevalence On The Growth Of The Peripheral Neuropathy Market: Powering Innovation and Expansion in the Global Peripheral Neuropathy Market by 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Peripheral Neuropathy Market Through 2025?
The valuation of the peripheral neuropathy market has experienced substantial expansion over the preceding years, projected to climb from its 2024 figure of $4.09 billion to reach $4.59 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.2%. This upward trajectory during the past period stems from several key factors, including the escalating incidence of long-term conditions such as diabetes, heightened public consciousness regarding methods to manage neuropathic discomfort, an aging global populace, the broadening of medical facilities, the accessibility of dedicated treatment sites, governmental efforts focused on enhancing neurological care provisions, and the increasing acceptance of innovative therapeutic approaches.

What's the Projected Size of the Global Peripheral Neuropathy Market by 2029?
Anticipating substantial expansion, the peripheral neuropathy market is projected to reach a valuation of $7.24 billion by the year 2029, driven by an impressive compound annual growth rate of 12.1%; this upward trajectory stems from several factors, including the escalating incidence of long-term conditions such as diabetes and cancer, breakthroughs in pharmaceutical approaches designed to combat neuropathic pain pathways, augmented funding allocated to discovering novel therapeutic methods, the uptake of digital health platforms aiding in remote oversight and tailored management protocols for neuropathy symptoms, a stronger emphasis on care plans centered around the individual patient, and enhanced availability of comprehensive healthcare services encompassing various specialties. Key developments shaping this market outlook involve a greater move towards individualized treatment strategies, the increasing application of sophisticated wearable technology for continuous tracking of symptoms and treatment efficacy, the broadening scope of telemedicine for remote patient interactions, the emergence of highly specific treatments targeting defined neuropathic pain mechanisms, progress made in areas like regenerative medicine, the incorporation of digital platforms delivering therapies such as cognitive behavioral interventions and mindfulness training, and sophisticated tooling being developed for earlier identification and ongoing observation of peripheral nerve damage.

View the full report here:
https://www.thebusinessresearchcompany.com/report/peripheral-neuropathy-global-market-report

Top Growth Drivers in the Peripheral Neuropathy Industry: What's Accelerating the Market?
The expanding incidence of diabetes is anticipated to serve as a major catalyst for the advancement of the peripheral neuropathy market in the coming period. Diabetes, defined as a persistent ailment involving elevated blood glucose concentrations arising from the body's failure to secrete or properly utilize insulin, is becoming more widespread, largely influenced by escalating obesity rates, inactive ways of life, and demographic shifts toward an older populace. This elevated sugar directly harms nerves over time, resulting in peripheral neuropathy symptoms like sensations of burning, prickling, or loss of feeling in the limbs, making rigorous blood sugar control essential for averting or slowing this complication's onset. Illustratively, data from April 2023 revealed that 4.3 million people in the UK had received a diabetes diagnosis, as reported by The British Diabetic Association, a charity focused on diabetes within the UK; moreover, registration figures for the 2021-22 period noted a surge of 148,951 new cases compared to the preceding year, and a further two million plus individuals in the nation face a high likelihood of developing type 2 diabetes, thus underscoring how the increasing burden of diabetes fuels the expansion of the peripheral neuropathy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16507&type=smp

What Trends Will Shape the Peripheral Neuropathy Market Through 2029 and Beyond?
Prominent players within the peripheral neuropathy sector are concentrating their efforts on engineering sophisticated tools, specifically point-of-care apparatus, intended to enhance both the identification and ongoing care of this ailment. A quantitative screening examination for peripheral neuropathy performed at the point of care functions as a swift diagnostic instrument, designed to quickly ascertain whether nerve impairment exists in individuals' limbs, especially those suffering from diabetes. To illustrate this trend, in the opening month of 2023, NeuroMetrix Inc., an American firm specializing in non-invasive medical apparatus production, rolled out the DPNCheck 2.0 point-of-care instrument for identifying peripheral neuropathy. This technology employs nerve conduction principles to register the widespread deterioration affecting peripheral nerves, a process that frequently results in incapacitating ailments like diabetic peripheral neuropathy (DPN). Its principal advantage lies in providing expedited patient screening by quantitatively measuring peripheral nerve function, thereby presenting itself as a superior and more precise alternative when contrasted with conventional assessment techniques like the use of monofilaments or tuning forks.

What Are the Main Segments in the Peripheral Neuropathy Market?
The peripheral neuropathymarket covered in this report is segmented -

1) By Type: Chemotherapy-Induced; Diabetic; Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS Associated; Idiopathic
2) By Diagnosis: Blood Test; Biopsy; Imaging; Other Diagnosis
3) By Treatment: Medications; Antidepressants; Anti-Seizure Medication; Pain Reliever; Topical Treatment; Therapies; Nerve Stimulation; Plasma Exchange; Physical Therapy; Other Treatments
4) By End-User: Hospitals; Clinics; Ambulatory Centers

Subsegments:
1) By Chemotherapy-Induced: Taxane-Induced Peripheral Neuropathy; Platinum-Based Drug-Induced Neuropathy; Other Chemotherapy-Induced Neuropathies
2) By Diabetic: Type 1 Diabetes-Induced Peripheral Neuropathy; Type 2 Diabetes-Induced Peripheral Neuropathy
3) By Human Immunodeficiency Virus (HIV) Or Acquired Immunodeficiency Syndrome (AIDS) Associated: HIV-Associated Peripheral Neuropathy; AIDS-Related Peripheral Neuropathy
4) By Idiopathic: Acute Idiopathic Neuropathy; Chronic Idiopathic Neuropathy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16507&type=smp

Which Top Companies are Driving Growth in the Peripheral Neuropathy Market?
Major companies operating in the peripheral neuropathy market are Pfizer Inc., Merck and Co. Inc., Novartis AG, Bristol Myers Squibb Co, AstraZeneca Plc, Abbott Laboratories, Eli Lilly and Co., Asahi Kasei Corporation, Daiichi Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Cadila Pharmaceuticals Ltd., Dr. Reddy's Laboratories, Cipla Ltd., Apotex Inc, Hikma Pharmaceuticals PLC, Lupin Limited, Grunenthal GmbH, ACI Limited, Lexicon Pharmaceuticals, Solasia Pharma KK, Helixmith Co. Ltd., PledPharma AB

Which Regions Will Dominate the Peripheral Neuropathy Market Through 2029?
North America was the largest region in the peripheral neuropathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral neuropathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16507

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.